Wipfli Financial Advisors’s United Therapeutics UTHR Stock Holding History

Wipfli Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$195K	Buy	+932	New	+$208K	0.01%	462

Other funds holding UTHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wipfli Financial Advisors's UTHR Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in United Therapeutics (UTHR) in Q3 2022: 932 shares worth $195K. The stake represents 0.01% of the portfolio and ranks #462 among its holdings.

461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

Wipfli Financial Advisors held 932 shares of United Therapeutics worth $195K as of Q3 2022.
United Therapeutics was a new Wipfli Financial Advisors position in Q3 2022.
United Therapeutics made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #462 holding.
461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.